Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects

Inclusion Criteria: Healthy male or female subjects aged 18-60 years (including boundary values) If a woman has no planned pregnancy within 6 months after signing the informed consent, and is willing to use effective contraception (e.g. condom, uterine cap, non-hormonal intrauterine device [IUD]) for at least 3 months from the first administration of the study intervention to the last administration of the study intervention; Or not fertile (e.g. surgical sterilization [bilateral oophorectomy, tubal ligation, or hysterectomy] or natural sterilization [continuous > 12 months without menstruation]) If male, agree to use effective contraception throughout the study intervention and for at least 3 months after the last dose of the study intervention, and do not donate sperm. General good health based on history, physical examination (screening and check-in assessment), vital signs and other screening assessments. Able to understand the research content, comply with the research protocol, and voluntarily sign the informed consent. Exclusion Criteria: Pregnant and lactating women. Patients with acute or chronic diseases, including but not limited to cardiovascular, digestive, respiratory, urinary, nervous, endocrine, immune, musculoskeletal, and skin conditions, were judged by the investigator. Any previous or existing hematological disorders or disorders, major liver disease, family history of bleeding/platelet disease. Previous or existing cancer (other than basal cell carcinoma or squamous cell carcinoma of the skin), or hygrosis. Have an autoimmune disease, immunosuppression, or any form of immune deficiency.